Study For Pregnant Women on Opiate Maintenance Therapy (Methadone or Buprenorphine)
Protocol: STUDY00004164
Full Title
Barriers and Facilitators of Breastfeeding in Women on Opioid Maintenance Therapy
This study enrolls pregnant women taking methadone or buprenorphine for opioid use disorder. The purpose of this study is to learn about the factors that can promote or prevent successful breastfeeding in these women from the perspective of the woman. We also want to explore how those factors change over time.
Breastfeeding is the most healthy choice for all mothers and newborns, but these benefits are especially important for women who take buprenorphine or methadone. Not only do their newborns have fewer withdrawal problems, but there are many other benefits as well. Unfortunately, many women taking medication for opioid use are not successful with breastfeeding.
This study will include several interviews with each participating woman, beginning in the last 3 months of their pregnancy. Interviews will happen again at 7-10 days after delivery of the baby, and again at 3, 6, and 12 weeks after the baby is born. Interviews will take place virtually by way of an online meeting platform, such as Zoom, or by telephone.

Technical Description

This longitudinal qualitative study will fill a gap in our understanding of the breastfeeding experiences of women who are on opioid maintenance therapy for opioid use disorder. Results will inform evidence-based interventions to support these womens breastfeeding efforts.
Compensation: Yes
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Woman ages 18+.
Must be pregnant and intend to breastfeed their newborn.
Stable on opioid maintenance therapy for opioid use disorder.
Age Group: Adults
Principal Investigator: MARGARET DOERZBACHER
+1 716-829-3229
Want to Learn More?
Enrollment Update

Due to COVID-19, new enrollment in research studies will be greatly limited. If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry. View the guidance for research participants for additional information.

Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email and someone will assist you.